Related Experiment Video
Updated: Aug 3, 2026
10:04
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Thalidomide-based treatment for HIV-associated multiple myeloma: a case report
1Division of Hematology, University of Washington, Seattle, Washington, USA.
The AIDS Reader
|October 4, 2003
Summary
This case study highlights a successful treatment for HIV-associated multiple myeloma using thalidomide, dexamethasone, and clarithromycin. The regimen achieved a significant antitumor response while maintaining immune health in the patient.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- HIV infection can cause a wide range of hematologic and immunologic issues.
- While HIV-associated B-cell neoplasms are more common, multiple myeloma is rare, with limited data on treatment outcomes.
Observation:
- A case of an HIV-infected male diagnosed with multiple myeloma presented with anemia and fatigue.
- The patient received a treatment regimen including thalidomide, dexamethasone, and clarithromycin.
Findings:
- The treatment resulted in a rapid and significant antitumor response.
- The patient maintained a normal CD4+ T-lymphocyte count and undetectable HIV viral load with manageable toxicities.
- Thalidomide demonstrated both antitumor and potential immunologic benefits.
Implications:
- Thalidomide shows promise as a treatment option for HIV-associated multiple myeloma due to its efficacy and tolerable side-effect profile.
- Further research into thalidomide for HIV-associated multiple myeloma is warranted.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.